Home sleep testing (HST) has become a cornerstone of modern sleep medicine, expanding access, accelerating diagnosis, and improving patient convenience. According to the American Academy of Sleep Medicine (AASM), HST is an appropriate diagnostic pathway for select patient populations when used within a structured clinical program. As healthcare systems continue shifting care beyond the hospital setting, HST is no longer optional. It is essential.
However, for hospital-based programs, how HST is implemented is just as important as whether it is offered.
Many current models are designed for scale rather than clinical complexity. This distinction is where challenges begin.
Hospitals Treat Complexity, Not Averages
Standardized HST models often rely on a single device and uniform workflows, typically centered on limited-signal technologies such as photoplethysmography (PPG). These approaches are effective for screening uncomplicated obstructive sleep apnea in lower-risk populations.
Hospital populations are fundamentally different. Patients frequently present with cardiovascular disease, pulmonary conditions, neuromuscular disorders, medication-related respiratory suppression, and overlapping sleep disorders.
In these cases, limited data collection can lead to:
• Inconclusive results
• Repeat testing
• Delays in diagnosis and treatment
• Reduced diagnostic confidence
What appears efficient at the outset can ultimately slow care and increase burden on both clinicians and staff.
Hospital programs are built around complexity. This requires diagnostic flexibility that standardized models often fail to provide.
Matching the Test to the Patient
A more effective approach aligns diagnostic tools with patient complexity.
Rather than relying on a single device, hospital-based programs are increasingly incorporating a range of testing options. Simpler systems may be appropriate for patients with a high likelihood of uncomplicated obstructive sleep apnea. More advanced, multi-channel devices provide deeper respiratory and cardiovascular insight for higher-risk patients.
This approach supports physician decision-making and reflects how medicine is practiced in hospital settings. Care is individualized, data-driven, and responsive to patient variability.
Why Diagnostic Depth Matters
The difference between limited and multi-parameter testing is not just technical—it is clinical.
Advanced HST configurations can capture respiratory effort, airflow, oxygen desaturation trends, heart rate variability, and body position, providing a more complete clinical picture and supporting more confident diagnosis and treatment planning.
In hospital settings, where sleep data may influence cardiology, pulmonary, or perioperative decisions, this level of insight is critical.
Integration and Operational Execution
Technology alone does not define a successful HST program. Equally important is how testing integrates into the broader care continuum.
HST must function as part of a coordinated system, integrating with in-lab polysomnography, physician workflows, and broader care pathways. Operational execution is equally important, requiring efficient management of scheduling, insurance authorization, patient communication, and referral tracking.
Without strong coordination from referral through interpretation, delays can impact both patient outcomes and provider workflows.
Limitations of Current HST Delivery Models
Many hospital programs rely on OEM direct-ship or single-device outsourcing models to expand access. While convenient, these approaches are not designed to support the complexity, integration, and scale required in hospital-based care.
OEM drop-ship programs are typically limited to a single device and a closed software ecosystem. While a quick solution for distribution, they often lack the flexibility needed to support diverse patient populations and may not fully integrate with hospital EMR systems, particularly when expanded patient communication, referral tracking, and workflow coordination are required.
Some hospitals attempt to maintain control through internal pickup or distribution programs. While this can replicate certain logistical advantages, it introduces significant operational burden. Staffing, device management, patient coordination, and technology infrastructure must all be managed internally, requiring a level of investment that is difficult to sustain.
Single-device outsourcing models present similar challenges. They may simplify initial implementation but limit the ability to match testing to patient complexity and often lack flexibility to adapt to evolving reimbursement and clinical demands.
The limitation across these models is not access. It is adaptability and integration.
More comprehensive outsourced management approaches address these gaps by enabling multi-device strategies aligned to clinical need and supporting flexible IT platforms that integrate with hospital systems. These platforms streamline workflows, support timely study interpretation, and allow programs to respond more effectively to reimbursement and regulatory changes.
For hospitals, the challenge is not simply implementing home sleep testing. It is building a model that can sustain clinical quality, operational efficiency, and financial performance at scale.
Reimbursement Changes and Program Sustainability
Hospitals must also prepare for changes in reimbursement.
Updates to CPT coding and payment structures for home sleep testing are expected to be recommended in mid-2026 and implemented by year-end. Ongoing evaluation by CMS continues to shape how diagnostic approaches are valued across care settings.
For hospital programs, this introduces both risk and opportunity.
Home sleep testing economics increasingly favor outsourced models, with lower per-test costs, higher throughput, and reduced capital investment. When supported by integrated digital platforms, these models also improve process flow, physician usability, and patient communication.
Programs that incorporate diagnostic flexibility and operational integration will be better positioned to adapt.
A More Resilient Model for Hospital-Based Care
As home sleep testing continues to expand, hospitals must balance access with clinical responsibility.
Programs that prioritize flexibility in testing approaches, alignment with physician decision-making, integration across the care continuum, and strong operational infrastructure are better positioned to deliver high-quality care and long-term sustainability.
The goal is not simply to test more patients. It is to deliver accurate, actionable insights that support complex clinical decisions.

Whitney Brenke, RRT, RPSGT
Whitney Brenke serves as Chief Operating Officer of Persante Health Care, the nation’s largest provider of hospital-based in-lab and home sleep testing (HST) programs. Persante partners exclusively with hospitals to design, implement, and manage comprehensive sleep programs that improve patient access, clinical outcomes, and long-term program performance.
She leads operational strategy across a nationwide network of hospital partners, supporting scalable models that integrate home sleep testing, in-lab diagnostics, and ongoing program optimization.
Learn more at Persante.com.






